• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Store » Books » The Revised ICH E8: A Guide to New Clinical Trial Requirements
The Revised ICH E8: A Guide to New Clinical Trial Requirements

The Revised ICH E8: A Guide to New Clinical Trial Requirements

$397.00
Books

Product Details

“The quality by design approach to clinical research (section 3.1)
involves focusing on critical to quality factors to ensure the protection of
study subjects, the generation of reliable and meaningful results,
and the management of risks to those factors (section 3.2)”

— General Considerations for Clinical Studies E8(R1)

With ICH E8(R1) adopted, your planning, design and conduct of clinical trials looks different. Make sure you’re ready to implement the new guidelines.

The Revised ICH E8: A Guide to New Clinical Trial Requirements management report explains the ICH E8 updates and guides you through assessing the impact of key concepts on current and future clinical development practices, including the framework and approaches for identifying quality-by-design and critical-to-quality factors. The report reviews these and other expectations:

  • The scope and general principles of the ICH E8(R1) guideline
  • The impact on current research practices and influences on SOPs, procedures, processes and documentation
  • The framework and approaches for identifying critical-to-quality factors
  • Clinical development areas that may be impacted by the adoption of the ICH E8(R1) guideline and approaches for compliance

Prepare for ICH E8(R1) now.

About the Expert
Leslie Sam is Principal Consultant, Wool Consulting Group, supporting the development and refinement of clinical quality management systems, issue management and clinical trial risk management in clinical research. She is an accomplished, results-driven and passionate clinical research and quality professional with 20+ years of transferable technical and leadership skills and business acumen. Ms. Sam has Six Sigma Black Belt certification (CSSBB) and Quality Improvement Associate certification issued by the American Society for Quality. She is co-author of three TransCelerate Group peer-reviewed journal articles on the topics of clinical quality management systems and issues management systems.

Who Will Benefit

  • Regulatory Affairs Professionals
  • Clinical Operations Personnel
  • Project Managers
  • Quality Professionals
  • Compliance Professionals
  • Clinical Development Professionals

PDF

$397.00
Add to Cart

Contributor:
Leslie Sam

ISBN-13:
978-1-60430-122-9

Publication date:
March 2020

Page count:
99


Our Guarantee
Not satisfied with your publication? For the PDF version, you must notify CenterWatch within 24 hours of receipt of purchase and we will refund 100 percent of your purchase price.

  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing